BUZZ-U.S. Stocks on the Move-Ebola drug developers, airline companies
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks fell on Wednesday, with investors spooked by the first diagnosis of Ebola in a patient in the United States, but the CBOE Volatility index pared back from earlier gains, suggesting further volatility may be limited. The Dow Jones industrial average was down 1.13 percent at 16,849.47 and the S&P 500 was down 0.85 percent at 1,955.55.
** TEKMIRA PHARMACEUTICAL CORP, $25.1399, +18.92 pct
** BIOCRYST PHARMACEUTICALS INC, $9.95, +1.74 pct
** SAREPTA THERAPEUTICS INC, $22.3011, +5.69 pct
** NEWLINK GENETICS CORP, $22.8999, +6.91 pct
** LAKELAND INDUSTRIES, $7.585, +9.14 pct
Shares of several pharmaceutical companies with potential Ebola treatments jumped after the U.S. Centers for Disease Control and Prevention confirmed on Tuesday the first case of the virus diagnosed in the country.
Shares of Lakeland Industries, which makes protective clothing for healthcare and first responders, also jumped.